PureTech Health (PRTC) Cash & Equivalents: 2019-2024
- PureTech Health's Cash & Equivalents was N/A to $228.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $228.0 million, marking a year-over-year change of. This contributed to the annual value of $141.5 million for FY2023, which is 5.56% down from last year.
- PureTech Health's Cash & Equivalents amounted to $228.0 million in Q2 2024, which was up 61.10% from $141.5 million recorded in Q4 2023.
- PureTech Health's 5-year Cash & Equivalents high stood at $465.7 million for Q4 2021, and its period low was $141.5 million during Q4 2023.
- Moreover, its 3-year median value for Cash & Equivalents was $149.9 million (2022), whereas its average is $173.1 million.
- As far as peak fluctuations go, PureTech Health's Cash & Equivalents skyrocketed by 205.14% in 2020, and later slumped by 67.82% in 2022.
- Quarterly analysis of 5 years shows PureTech Health's Cash & Equivalents stood at $403.9 million in 2020, then increased by 15.31% to $465.7 million in 2021, then tumbled by 67.82% to $149.9 million in 2022, then decreased by 5.56% to $141.5 million in 2023, then reached $228.0 million in 2024.
- Its Cash & Equivalents was $228.0 million in Q2 2024, compared to $141.5 million in Q4 2023 and $149.9 million in Q4 2022.
